STORM in the News

LaBiotech: Meet the First Company in the Brand New Field of Epitranscriptomics

Clara Rodríguez Fernández spoke with Keith Blundy, CEO STORM Therapeutics and Hakan Goker, M Ventures about leading the development of the first treatments to target a new layer of genetic information encoded in the RNA.